Edgewise Therapeutics Inc
EWTXHealthcare|Biotechnology|USA
$45.41
-2.94 (-6.08%)
Tangible Book
$4.59
Earnings Power
$4.34
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (85)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer | 2026-07-01 | SELL | 200,000 | $39.41 | $7882K |
| Donovan Joanne M. | CMO | 2026-05-05 | SELL | 55,230 | $37.88 | $2092.1K |
| Donovan Joanne M. | CMO | 2026-04-01 | SELL | 28,662 | $32.31 | $926.1K |
| Donovan Joanne M. | CMO | 2026-03-31 | SELL | 21,338 | $32.12 | $685.4K |
| Donovan Joanne M. | CMO | 2026-03-27 | SELL | 16,358 | $30.98 | $506.8K |
| Edris Badreddin | Director | 2026-01-21 | SELL | 115,471 | $29.44 | $3399.5K |
| Russell Alan J | Chief Scientific Officer | 2025-11-12 | SELL | 100,000 | $21.12 | $2112K |
| Fox Jonathan C | Director | 2025-11-11 | BUY | 10,700 | $18.64 | $199.4K |
| Russell Alan J | Chief Scientific Officer | 2025-08-26 | SELL | 100,000 | $14.6 | $1460K |
| MOORE JOHN R | General Counsel | 2025-08-12 | SELL | 2,098 | $13.39 | $28.1K |
| Derakhshan Behrad | Chief Business Officer | 2025-08-12 | SELL | 2,491 | $13.39 | $33.4K |
| Carruthers R Michael | CFO | 2025-08-12 | SELL | 1,428 | $13.39 | $19.1K |
| Russell Alan J | Chief Scientific Officer | 2025-08-12 | SELL | 1,907 | $13.39 | $25.5K |
| KOCH KEVIN | President and CEO | 2025-08-12 | SELL | 7,972 | $13.39 | $106.7K |
| Donovan Joanne M. | CMO | 2025-08-12 | SELL | 2,862 | $13.39 | $38.3K |
| Russell Alan J | Chief Scientific Officer | 2025-05-02 | SELL | 1,551 | $16.45 | $25.5K |
| MOORE JOHN R | General Counsel | 2025-05-02 | SELL | 1,930 | $16.45 | $31.7K |
| KOCH KEVIN | President and CEO | 2025-05-02 | SELL | 4,276 | $16.45 | $70.3K |
| Donovan Joanne M. | CMO | 2025-05-02 | SELL | 5,187 | $16.45 | $85.3K |
| Derakhshan Behrad | Chief Business Officer | 2025-05-02 | SELL | 1,691 | $16.45 | $27.8K |
| Carruthers R Michael | CFO | 2025-05-02 | SELL | 1,314 | $16.45 | $21.6K |
| Thompson Peter A. | Director, 10% Owner | 2025-04-03 | BUY | 496,771 | $20.13 | $10000K |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 2025-04-03 | BUY | 496,771 | $20.13 | $10000K |
| Russell Alan J | Chief Scientific Officer | 2025-03-07 | SELL | 200 | $30.02 | $6K |
| KOCH KEVIN | President and CEO | 2025-03-07 | SELL | 100 | $30 | $3K |
| Russell Alan J | Chief Scientific Officer | 2025-02-06 | SELL | 9,215 | $30.04 | $276.8K |
| KOCH KEVIN | President and CEO | 2025-02-06 | SELL | 9,536 | $30.13 | $287.3K |
| Derakhshan Behrad | Chief Business Officer | 2025-02-05 | SELL | 10,000 | $30.03 | $300.3K |
| Donovan Joanne M. | CMO | 2025-01-28 | SELL | 25,000 | $27.63 | $690.8K |
| Russell Alan J | Chief Scientific Officer | 2024-12-30 | SELL | 100,000 | $27.37 | $2737K |
| Semigran Marc | Chief Development Officer | 2024-12-24 | SELL | 29,709 | $29.69 | $882.1K |
| MOORE JOHN R | General Counsel | 2024-09-23 | SELL | 70,922 | $28.15 | $1996.5K |
| Russell Alan J | Chief Scientific Officer | 2024-09-20 | SELL | 75,000 | $28.27 | $2120.3K |
| Donovan Joanne M. | CMO | 2024-09-20 | SELL | 7,162 | $28.29 | $202.6K |
| Derakhshan Behrad | Chief Business Officer | 2024-09-20 | SELL | 42,068 | $29.03 | $1221.2K |
| Carruthers R Michael | CFO | 2024-09-20 | SELL | 125,092 | $28.57 | $3573.9K |
| MOORE JOHN R | General Counsel | 2024-05-02 | SELL | 1,956 | $18.91 | $37K |
| Carruthers R Michael | CFO | 2024-05-02 | SELL | 2,157 | $18.91 | $40.8K |
| Derakhshan Behrad | Chief Business Officer | 2024-05-02 | SELL | 1,718 | $18.91 | $32.5K |
| Russell Alan J | Chief Scientific Officer | 2024-05-02 | SELL | 1,576 | $18.91 | $29.8K |
| Donovan Joanne M. | CMO | 2024-05-02 | SELL | 3,682 | $18.91 | $69.6K |
| KOCH KEVIN | President and CEO | 2024-05-02 | SELL | 3,152 | $18.91 | $59.6K |
| MOORE JOHN R | General Counsel | 2024-02-09 | SELL | 29,835 | $20 | $596.7K |
| Derakhshan Behrad | Chief Business Officer | 2024-02-09 | SELL | 10,000 | $20.03 | $200.3K |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 2024-01-23 | BUY | 454,545 | $11 | $5000K |
| Thompson Peter A. | Director, 10% Owner | 2024-01-23 | BUY | 454,545 | $11 | $5000K |
| Carruthers R Michael | CFO | 2024-01-23 | SELL | 90,000 | $15.78 | $1420.2K |
| MOORE JOHN R | General Counsel | 2023-12-27 | SELL | 8,497 | $10.5 | $89.2K |
| Fox Jonathan C | Director | 2023-12-26 | BUY | 10,857 | $9.3 | $101K |
| Russell Alan J | Chief Scientific Officer | 2023-12-26 | SELL | 172,585 | $9.33 | $1610.2K |
| Derakhshan Behrad | Chief Business Officer | 2023-05-02 | SELL | 1,747 | $8.9 | $15.5K |
| MOORE JOHN R | General Counsel | 2023-05-02 | SELL | 1,897 | $8.9 | $16.9K |
| Carruthers R Michael | CFO | 2023-05-02 | SELL | 1,336 | $8.9 | $11.9K |
| Russell Alan J | Chief Scientific Officer | 2023-05-02 | SELL | 1,602 | $8.9 | $14.3K |
| Donovan Joanne M. | CMO | 2023-05-02 | SELL | 3,254 | $8.9 | $29K |
| KOCH KEVIN | President and CEO | 2023-05-02 | SELL | 3,203 | $8.9 | $28.5K |
| MOORE JOHN R | General Counsel | 2022-10-03 | SELL | 4,730 | $9.76 | $46.2K |
| Thompson Peter A. | Director, 10% Owner | 2022-09-16 | BUY | 484,496 | $10.32 | $5000K |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 2022-09-16 | BUY | 484,496 | $10.32 | $5000K |
| Novo Holdings A/S | 10% Owner | 2022-09-14 | BUY | 484,496 | $10.32 | $5000K |
| MOORE JOHN R | General Counsel | 2022-09-06 | SELL | 4,730 | $10.91 | $51.6K |
| MOORE JOHN R | General Counsel | 2022-08-03 | SELL | 9,232 | $9.31 | $85.9K |
| MOORE JOHN R | General Counsel | 2022-07-06 | SELL | 9,232 | $8.37 | $77.3K |
| MOORE JOHN R | General Counsel | 2022-06-21 | SELL | 67,927 | $6.83 | $463.9K |
| MOORE JOHN R | General Counsel | 2022-06-15 | SELL | 26,381 | $6.08 | $160.4K |
| MOORE JOHN R | General Counsel | 2022-06-10 | SELL | 27,306 | $6.44 | $175.9K |
| MOORE JOHN R | General Counsel | 2022-06-07 | SELL | 47,287 | $6.26 | $296K |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 2022-05-18 | BUY | 138,000 | $7.21 | $995K |
| Thompson Peter A. | Director, 10% Owner | 2022-05-18 | BUY | 138,000 | $7.21 | $995K |
| MOORE JOHN R | General Counsel | 2022-05-16 | SELL | 10,800 | $7.42 | $80.1K |
| Russell Alan J | Chief Scientific Officer | 2021-11-15 | SELL | 479 | $19.11 | $9.2K |
| Russell Alan J | Chief Scientific Officer | 2021-11-12 | SELL | 69,740 | $19.91 | $1388.5K |
| Russell Alan J | Chief Scientific Officer | 2021-11-08 | SELL | 29,451 | $19.82 | $583.7K |
| Russell Alan J | Chief Scientific Officer | 2021-11-03 | SELL | 44,172 | $17.88 | $789.8K |
| Russell Alan J | Chief Scientific Officer | 2021-10-15 | SELL | 7,182 | $18.17 | $130.5K |
| Russell Alan J | Chief Scientific Officer | 2021-10-11 | SELL | 1,270 | $18.02 | $22.9K |
| Russell Alan J | Chief Scientific Officer | 2021-10-08 | SELL | 21,028 | $18.39 | $386.7K |
| Russell Alan J | Chief Scientific Officer | 2021-10-05 | SELL | 5,778 | $18.24 | $105.4K |
| Russell Alan J | Chief Scientific Officer | 2021-09-29 | SELL | 26,454 | $17.1 | $452.4K |
| Russell Alan J | Chief Scientific Officer | 2021-09-27 | SELL | 58,546 | $18.3 | $1071.4K |
| Novo Holdings A/S | 10% Owner | 2021-03-30 | BUY | 625,000 | $16 | $10000K |
| Flynn James E | 2021-03-30 | BUY | 625,000 | $16 | $10000K | |
| ROOT JONATHAN D | Director | 2021-03-30 | BUY | 15,625 | $16 | $250K |
| Thompson Peter A. | Director, 10% Owner | 2021-03-30 | BUY | 359,375 | $16 | $5750K |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 2021-03-30 | BUY | 359,375 | $16 | $5750K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked